Business Wire

Velodyne Lidar Calls for Action to Improve Pedestrian Safety

Share

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a white paper, written by Velodyne experts and published by SAE International, that calls for independent performance testing of driver assistance systems to be expanded to include dark, nighttime scenarios, as more than 75 percent of pedestrian fatalities occur in low-to-no light conditions. The change would address a gap in current testing protocols that primarily look at daytime conditions and largely overlook the risks to pedestrians from driver assistance systems which perform poorly in dark, nighttime conditions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915005189/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Diagram of the Safety of the Intended Functionality (SOTIF) standard validation process, highlighting steps in the design, implementation and testing phases to ensure the safety function performance aligns with design intent. The SOTIF approach provides a methodology for identifying and maximizing the range of scenarios in which a vehicle can be expected to function safely under normal operation or with reasonably foreseeable misuse. (Graphic: Velodyne Lidar)

The white paper, called “Designing and assessing vehicle safety functions with a use case approach,” is available on the SAE International website. It can also be downloaded from the Velodyne website.

Recently, the National Highway Transportation Safety Administration (NHTSA) reported that motor vehicle traffic fatalities rose 10.5 percent in the first quarter of 2021 from the same time in 2020, with the vast majority of fatalities occurring in dark conditions. NHTSA also reports this staggering increase in deaths – an estimated 8,730 in three months – comes despite a decrease of 14.9 billion vehicle miles traveled during the same time. To address these tragedies, most new vehicles offer advanced driver assistance systems (ADAS), equipped with Pedestrian Automatic Emergency Braking (PAEB) as a standard optional feature.

Addressing PAEB Performance Limitations

PAEB systems are a foundational element for both AV and ADAS applications. They provide automatic braking for vehicles when pedestrians are in the path of the vehicle’s travel and the driver has taken insufficient action to avoid an imminent crash. However, current systems utilizing camera and radar technology frequently fail to protect pedestrians in dark conditions according to independent testing by the National Highway Traffic Safety Administration (NHTSA) and the American Automobile Association (AAA).

To reflect real-life conditions, the white paper proposes expanding future PAEB testing protocols to include tests conducted in dark, nighttime conditions. The new tests would be conducted in less than one lux ambient illuminance, using low-beam headlights and without streetlights. This change would provide the public with useful information on the performance of pedestrian detection systems in low-light conditions that occur on roadways.

To demonstrate how expanded testing would work, the white paper details the results of nighttime PAEB tests conducted by Velodyne. The tests evaluated a highly-rated PAEB system using current camera and radar-based technology and Velodyne’s PAEB system that uses Velodyne’s lidar sensors and Vella™ software. In these nighttime conditions, the camera and radar-based PAEB system failed in all five scenarios while the lidar-based system avoided a crash in every situation tested.

“PAEB systems can potentially have safety hazards related to nighttime driving and speed without system failure,” said Mircea Gradu, SVP of Automotive Programs, Velodyne Lidar. “Their performance can fall short under these real-world conditions due to limitations of sensors or software. Accurate situational awareness by ADAS and AVs is essential to safety.”

In March of 2021, the Governors Highway Safety Association reported a staggering 21 percent increase in the pedestrian fatality rate from 2019 to 2020. Additionally, on average, 100 lives are lost each day in motor vehicle crashes. While advanced driver assistance systems that perform in low- or no-light conditions have been available for years, they have yet to be wide adopted by automakers, even though they’ve proven to prevent crashes. Nearly four years ago, vehicles with mere front crash prevention technology had 64 percent fewer crashes with injuries than vehicles without it.

“With dark, nighttime conditions so dangerous for pedestrians, it is imperative vehicle assessment organizations expand PAEB testing in ambient light conditions of less than one lux,” said David Heeren, Director, Technology Research, Velodyne Lidar. “Tests performed by NHTSA and AAA demonstrate nighttime performance represents a major opportunity for improvement in current PAEB systems. Velodyne testing shows the efficacy of our lidar-based solution, which can strengthen a vehicle’s functional safety capabilities and address scenarios that cause thousands of pedestrian fatalities annually.”

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne, the global leader in lidar, is known for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com.

Forward Looking Statements

This press release contains “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, and competition. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “can,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include uncertainties regarding government regulation and adoption of lidar, the uncertain impact of the COVID-19 pandemic on Velodyne’s and its customers’ businesses; Velodyne’s ability to manage growth; Velodyne’s ability to execute its business plan; uncertainties related to the ability of Velodyne’s customers to commercialize their products and the ultimate market acceptance of these products; the rate and degree of market acceptance of Velodyne’s products; the success of other competing lidar and sensor-related products and services that exist or may become available; uncertainties related to Velodyne’s current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne’s intellectual property; and general economic and market conditions impacting demand for Velodyne’s products and services. For more information about risks and uncertainties associated with Velodyne’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Velodyne’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. All forward-looking statements in this press release are based on information available to Velodyne as of the date hereof, Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Velodyne Investor Relations
InvestorRelations@velodyne.com

Velodyne Media
Codeword
Liv Allen
velodyne@codewordagency.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LabGenius Appoints Dr. Didier Landais as Chief Operating Officer22.9.2021 07:00:00 EEST | Press release

LabGenius, the machine learning (ML)-driven protein engineering company, has announced the appointment of Didier Landais Ph.D. as Chief Operating Officer. In this role, Didier will leverage his wealth of experience in business and clinical development to lead the commercialization of LabGenius’ drug discovery platform, EVA TM . This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005586/en/ LabGenius Appoints Dr. Didier Landais as Chief Operating Officer (Photo: Business Wire) “I’m delighted that Didier has joined the team,” said Dr. James Field, Founder and CEO of LabGenius. “Didier is a seasoned operator with 30 years of pharmaceutical industry experience and I’m looking forward to working with him as we rapidly grow the company. It’s a testament to the progress we have made at LabGenius and the exciting opportunities we have ahead of us that we were able to attract someone of Didier’s calibre to join us on our journey.” D

Mastercard Launches Strive: a Global Small Business Initiative to Accelerate Economic Recovery22.9.2021 06:20:00 EEST | Press release

Micro and small enterprises are important contributors to job creation and global economic development, representing approximately 90% of business and more than 50% of employment worldwide. However, the pandemic necessitated a rapid shift to digital platforms and processes that have created new opportunities but also pushed many to the brink of failure. To address the transition to digital, Mastercard - through the Center for Inclusive Growth - today launched Strive, a global initiative focused on strengthening the financial resilience of small businesses and supporting their recovery and growth. With an initial philanthropic investment of $25 million from the Mastercard Impact Fund, Strive will help more than five million micro and small businesses around the world access the tools and resources they need to digitize. “When small businesses thrive our local communities and economies thrive, but when they struggle, the impact is widespread,” said Michael Miebach, CEO of Mastercard. “Wh

Moody’s Announces Participation in New GFANZ Alliance: Commits to Align Products and Services to Achieve Net-Zero Greenhouse Gas Emissions by 205022.9.2021 02:01:00 EEST | Press release

Moody’s Corporation (NYSE: MCO) today announced its participation in launching the Net Zero Financial Services Provider Alliance as part of the Glasgow Financial Alliance for Net Zero (GFANZ). As a founding member, Moody’s commits to align all of its relevant products and services to achieve net-zero greenhouse gas emissions by 2050, in addition to reducing its own operational emissions. “Climate change is the world’s greatest risk multiplier and a profound challenge for economies and communities alike. The entire financial industry must take on the shared challenge of enabling an urgent shift to a resilient and sustainable economy. Aligning products and services with net-zero by 2050 will improve decision-making and accelerate the flow of capital to support the transition,” said Rob Fauber, President and Chief Executive Officer of Moody’s Corporation. “We are delighted to join the Net Zero Financial Services Provider Alliance as our latest step to empower organizations in making more

Former Irish Prime Minister Bertie Ahern Announces The World Carbon Neutrality Forum22.9.2021 02:01:00 EEST | Press release

The "World Carbon Neutrality Forum" (WCNF) was announced today by the former President of the European Council (2004) and former Irish Prime Minister Bertie Ahern. Mr Ahern is currently co-chair of the Interaction of Council of Former Heads of State and Government, and the Eco Global Forum. The date of 22nd September has been chosen to mark the first anniversary of President Xi’s double carbon commitment and his efforts towards a community with a shared future. The Forum is established to promote climate cooperation between China, the United States, Europe, and the rest of the World. In its first year of operation, the World Carbon Neutrality Forum will be held virtually and transmitted by a dedicated video platform called the World Carbon Neutrality Media Network. The Forum will be based on a Davos model and will seek to stimulate thoughts globally by leadership on decarbonisation. It is a pluralistic organisation which will meet each quarter and will invite current and former Heads o

Science, Innovation, and Inclusion Are Vital in Addressing the World’s Most Pressing Issues, Says PMI CEO in Speech at Concordia Summit21.9.2021 23:24:00 EEST | Press release

Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (PMI) (NYSE: PM), today delivered remarks at the 2021 Concordia Annual Summit. Olczak discussed the need to draw on the lessons learned from the global response to COVID-19 and create transparent frameworks and partnerships that harness innovation to build a better world. He explained the importance of focusing on peer-reviewed science to tackle major global issues—including environmental pressure, social inequality, health pandemic, and smoking. Olczak described how the exclusionary practices of many anti-tobacco organizations and NGOs are making it harder for PMI to deliver tobacco harm reduction solutions by introducing scientifically substantiated alternatives as the company moves away from making and selling cigarettes. The Concordia Annual Summit, which coincides with the United Nations General Assembly (UNGA) meeting, convenes the world’s most prominent business, government, and nonprofit leaders to foster

‘Hidden Gem’ Arrives in Rotterdam to be Transformed into Nodule Collection Vessel for The Metals Company21.9.2021 19:37:00 EEST | Press release

The Metals Company (Nasdaq: TMC) today announced that the 228-meter-long former drill ship renamed the Hidden Gem has arrived in Rotterdam, The Netherlands to begin its conversion into what is expected to be the first ship classified as a sub-sea mining vessel by the American Bureau of Shipping. TMC’s strategic partner Allseas acquired the former ultra-deep-water drill ship, which can accommodate 200 people, in March of 2020, as her configuration is well-suited for modifications that will enable the deployment at sea of a 4.5 kilometer-long riser to bring polymetallic nodules up from the seafloor. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005945/en/ Hidden Gem vessel (Photo: Business Wire) In partnership with The Metals Company (formerly DeepGreen Metals Inc.), Allseas is developing a deep-sea mineral collection system to responsibly recover polymetallic nodules from the ocean floor and transfer them to the surfac

Rhizen Pharmaceuticals AG Announces First Patient Dosed in a Phase 2 Study of RP7214 in Covid-19 Patients21.9.2021 19:36:00 EEST | Press release

Rhizen Pharmaceuticals AG, a clinical-stage oncology & inflammation-focussed biopharmaceutical company, today announced that the first patient has been dosed in a Phase 2 clinical trial of RP7214, a small molecule oral dihydroorotate dehydrogenase (DHODH) Inhibitor. The randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy & safety of oral RP7214, in covid-19 patients with mild, symptomatic disease with an underlying risk factor on the background of promising preclinical efficacy & phase 1 healthy volunteer safety. The study is being conducted in India across 12 centres in coordination with Rhizen’s India affiliate, Incozen Therapeutics Pvt ltd., and is designed to enrol up to 204 patients across both study arms. Viral replication involves a huge demand for building blocks and relies on nucleotides derived from host cells. DHODH is a rate-limiting enzyme in the pyrimidine biosynthesis pathway, inhibition of which leads to depletion of host nucleotide po

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom